'A global outlier': how drug firms are fighting back against UK tax increases

The Pharmaceutical Journal from the Royal Pharmaceutical Society

Related Keywords

Ireland ,United Kingdom ,British ,Olivier Wouters ,Eli Lilly ,Laura Steele ,Mark Sculpher ,Hugh Taylor ,David Watson ,Jessamy Baird ,Haran Maheson ,University Of York Centre For Health Economics ,Gilead Sciences United Kingdom ,London School Of Economics ,Branded Health Service Medicines Costs Regulations ,British Generic Manufacturers Association ,Department Of Health ,Association Of The British Pharmaceutical Industry ,National Institute For Health ,Services Negotiating Committee ,Voluntary Scheme ,Branded Medicines Pricing ,British Pharmaceutical Industry ,Branded Health Service Medicines ,Northern Europe ,Pharmaceutical Journal ,United Kingdom Based ,Sanofi United Kingdom ,Mike Dent ,Pharmaceutical Services Negotiating Committee ,National Institute ,Care Excellence ,Bayer United ,London School ,Social Care ,Health Economics ,